Select for export Psilocybin for Depression: From Credibility to Feasibility, What’s Missing? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/ph16010068 PubMed 36678564 Copy citation Copy BibTeX Pharmaceuticals 2022-12-30 Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella OpenAlex Published psilocybin Depression Other More
Select for export High dose of psilocybin effective for treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.30970 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2022-12-26 Authors unavailable OpenAlex Published psilocybin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.2821 PubMed 36507738 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2022-12-11 Friederike Holze, A. Becker, Karolina E. Kolaczynska, Urs Duthaler, Matthias E. Liechti OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyClinical Trial Clinical Trial More
Select for export History of epilepsy increases risk of psychedelic-induced seizures Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.30967 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2022-12-09 Authors unavailable OpenAlex Published psilocybin DepressionAddictionPharmacology Observational Study More
Select for export Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1227/neu.0000000000002275 PubMed 36512813 Copy citation Copy BibTeX Unknown journal 2022-12-07 Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-022-06286-3 PubMed 36469097 Copy citation Copy BibTeX Psychopharmacology 2022-12-04 Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy OpenAlex Published psilocybin Receptor PharmacologyPersonality ChangeAnimal Study Animal Study More
Select for export Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221125354 PubMed 36433778 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-25 Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R. Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Body mass index (BMI) does not predict responses to psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131994 PubMed 36373934 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-11-13 Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T Europe PMC Published psilocybin Receptor PharmacologyWellbeingEmotional Processing Other More
Select for export Psilocybin-assisted therapy reduces heavy drinking in patients with AUD Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.30946 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2022-11-02 Authors unavailable OpenAlex Published psilocybin AddictionPharmacologyRandomized Controlled Trial Randomized Controlled Trial More
Select for export Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsptsci.2c00177 PubMed 36407948 Copy citation Copy BibTeX ACS Pharmacology & Translational Science 2022-11-01 Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK Europe PMC Published psilocybinpsilocin Receptor PharmacologyAnimal StudyIn Vitro Study Animal Study More
Select for export The psychedelic renaissance: can psilocybin possibly combat depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/gh9.0000000000000089 Copy citation Copy BibTeX International Journal of Surgery Global Health 2022-10-31 Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh OpenAlex Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221127304 PubMed 36314881 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-10-30 Jones GM. Europe PMC Published psilocybin DepressionObservational StudyDrug Interactions Observational Study More
Select for export Predictors of Psychedelic Experience: A Thematic Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2129885 PubMed 36197103 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-10-04 McCartney AM, McGovern HT, De Foe A. Europe PMC Published psilocybin Mechanism of Action Other More
Select for export To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1037/pha0000597 PubMed 36048112 Copy citation Copy BibTeX Experimental and Clinical Psychopharmacology 2022-08-31 Christensen JA, Fipps DC, Bostwick JM. Europe PMC Published psilocybin AddictionBrain ImagingReview Article Review Article More
Select for export Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2022.113612 PubMed 36049313 Copy citation Copy BibTeX Biomedicine & Pharmacotherapy 2022-08-29 Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE. Europe PMC Published psilocybinpsilocin Mechanism of ActionReceptor PharmacologyAnimal Study Animal Study More
Select for export Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109214 PubMed 35973601 Copy citation Copy BibTeX Unknown journal 2022-08-12 Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS Europe PMC Published psilocybin Review Article Review Article More
Select for export The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06187-5 PubMed 35939083 Copy citation Copy BibTeX Psychopharmacology 2022-08-07 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L Europe PMC Published psilocybin DepressionEmotional ProcessingClinical Trial Randomized Controlled Trial More
Select for export Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852922000888 PubMed 35811423 Copy citation Copy BibTeX Unknown journal 2022-07-10 Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF Europe PMC Published psilocybinpsilocin DepressionAnxietyPharmacology Review Article More
Select for export Natural language signatures of psilocybin microdosing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06170-0 PubMed 35676541 Copy citation Copy BibTeX Psychopharmacology 2022-06-08 Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M Europe PMC Published psilocybin MicrodosingWellbeingCreativity Other More
